Strategy + Evidence
Stratevi is a leading biotechnology research company dedicated to driving value and ensuring optimal access to therapy for patients. Located at 312 Arizona Ave, Santa Monica, California 90401, US, with an additional location at 1 Lincoln Street, 29th Floor, Boston, Massachusetts 02111, US, Stratevi partners with biotechnology, pharmaceutical, and medical device companies to creatively develop and communicate evidence. Stratevi seamlessly combines strategy and evidence to provide comprehensive solutions.
Stratevi offers a wide array of services, including value proposition development, strategic planning, study design recommendations, and competitive simulations. The company also specializes in ICER reviews, real-world outcome studies, economic models, prevalence-based outcome models, and retrospective database analyses. These services enable Stratevi to deliver exceptional results and support its clients in achieving their strategic goals.
Through value dossiers, publications, brand access toolkits, interactive training solutions, posters, and manuscripts, Stratevi ensures that the value of therapies is effectively communicated. Stratevi is committed to advancing healthcare through innovative research and strategic partnerships. We invite the management team at Stratevi to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.
Compare Stratevi with 3 companies in Biotechnology-Research
| Comparison Field |
StrateviMain Company |
Evidinno Outcomes Re...View Profile |
ConnectHEORView Profile |
MedaffconView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2020 | 2009 |
|
Company Size
|
— | 11-50 | 11-50 | 11-50 |
|
City
|
Santa Monica, California | Vancouver, British Columbia | London, England | Espoo, Uusimaa |
|
Country
|
United States | Canada | United Kingdom | Finland |
|
Skills & Keywords
Comparing with main company
|
25 Total Skills
Biotechnology
Pharmaceutical
Medical Device
Value Proposition
Strategic Planning
Real World Evidence
Health Economics
Patient Reported Outcomes
Cost Model
Value Communication
Strategy Consulting
Consultant
Observational Studies
Comparative Effectiveness Research
Outcomes Research
HEOR
Rare & Orphan Disease
Cost Effectiveness
ICER
Payers
HRQOL
Value Proposition Development
Biotech
HTA
Health Technology Assessment
|
16 Total
16 Unique
Unique Skills:
Drug Reimbursement
Epidemiology
Health Services Research
Market Access
Medical Writing
Meta-analysis
+10
|
14 Total
14 Unique
Unique Skills:
Consultancy
Data Analysis
Data Analytics
Decision Modelling
Evidence Synthesis
Health Economic Modelling
+8
|
28 Total
28 Unique
Unique Skills:
AI
Artificial intelligence
Biobanks
Cost-Effectiveness
Data analysis
Data Science
+22
|
Other organizations in the same industry
This company is also known as